20.08.2012 • News

Bayer Sues Warner Chilcott for Patent Infringement

Warner Chilcott said German drugmaker Bayer filed a complaint against the U.S. pharmaceutical company, alleging that Warner's oral contraceptive drug Lo Loestrin FE infringes a Bayer patent. According to the complaint filed in a U.S. district court, Bayer is seeking an injunction on the product along with unspecified monetary damages, Warner said in a filing. New Jersey-based Warner said it would defend the litigation as it believes the complaint lacks merit.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read